[go: up one dir, main page]

GT200000138CA - GENE OF STEPTOMYCES AVERMITILIS THAT DIRECTS THE RELATIONSHIP OF AVERMECTINES B1: B2 (FRACTIONARY APPLICATION NO.3, DERIVED FROM LAPATENT PI-2000-0138) - Google Patents

GENE OF STEPTOMYCES AVERMITILIS THAT DIRECTS THE RELATIONSHIP OF AVERMECTINES B1: B2 (FRACTIONARY APPLICATION NO.3, DERIVED FROM LAPATENT PI-2000-0138)

Info

Publication number
GT200000138CA
GT200000138CA GT200000138CM GT200000138M GT200000138CA GT 200000138C A GT200000138C A GT 200000138CA GT 200000138C M GT200000138C M GT 200000138CM GT 200000138 M GT200000138 M GT 200000138M GT 200000138C A GT200000138C A GT 200000138CA
Authority
GT
Guatemala
Prior art keywords
avermitilis
lapatent
avermectines
fractionary
steptomyces
Prior art date
Application number
GT200000138CM
Other languages
Spanish (es)
Inventor
Kim Jonelle Stutzman-Engwall
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GT200000138CA publication Critical patent/GT200000138CA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/76—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Actinomyces; for Streptomyces
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/181—Heterocyclic compounds containing oxygen atoms as the only ring heteroatoms in the condensed system, e.g. Salinomycin, Septamycin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides
    • C12P19/60—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • C12P19/62—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides
    • C12P19/60—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • C12P19/62—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin
    • C12P19/623—Avermectin; Milbemycin; Ivermectin; C-076

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to polynucleotide molecules comprising nucleotide sequences encoding an aveC gene product, which polynucleotide molecules can be used to alter the ratio or amount of class 2:1 avermectins produced in fermentation cultures of S. avermitilis. The present invention further relates to vectors, host cells, and mutant strains of S. avermitilis in which the aveC gene has been inactivated, or mutated so as to change the ratio or amount of class 2:1 avermectins produced.
GT200000138CM 1999-08-12 2000-08-11 GENE OF STEPTOMYCES AVERMITILIS THAT DIRECTS THE RELATIONSHIP OF AVERMECTINES B1: B2 (FRACTIONARY APPLICATION NO.3, DERIVED FROM LAPATENT PI-2000-0138) GT200000138CA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/372,934 US6248579B1 (en) 1998-02-13 1999-08-12 Streptomyces avermitilis gene directing the ratio of B2:B1 avermectins

Publications (1)

Publication Number Publication Date
GT200000138CA true GT200000138CA (en) 2002-02-02

Family

ID=23470234

Family Applications (2)

Application Number Title Priority Date Filing Date
GT200000138CM GT200000138CA (en) 1999-08-12 2000-08-11 GENE OF STEPTOMYCES AVERMITILIS THAT DIRECTS THE RELATIONSHIP OF AVERMECTINES B1: B2 (FRACTIONARY APPLICATION NO.3, DERIVED FROM LAPATENT PI-2000-0138)
GT200000138A GT200000138A (en) 1999-08-12 2000-08-11 STREPTOMYCES GENE AVERMITILIS THAT DIRECTS THE RELATIONSHIP OF AVERMECTINES B2: B1 (1).

Family Applications After (1)

Application Number Title Priority Date Filing Date
GT200000138A GT200000138A (en) 1999-08-12 2000-08-11 STREPTOMYCES GENE AVERMITILIS THAT DIRECTS THE RELATIONSHIP OF AVERMECTINES B2: B1 (1).

Country Status (37)

Country Link
US (8) US6248579B1 (en)
EP (1) EP1200605B1 (en)
JP (2) JP3688640B2 (en)
KR (1) KR100486006B1 (en)
CN (1) CN1186447C (en)
AP (2) AP2002002417A0 (en)
AR (1) AR021450A1 (en)
AT (1) ATE283363T1 (en)
AU (1) AU779756B2 (en)
BG (1) BG106478A (en)
BR (1) BR0013093A (en)
CA (1) CA2381427A1 (en)
CO (1) CO5290296A1 (en)
CZ (1) CZ2002297A3 (en)
DE (1) DE60016231T2 (en)
EA (1) EA004569B1 (en)
ES (1) ES2231214T3 (en)
GT (2) GT200000138CA (en)
HK (1) HK1046536B (en)
HR (1) HRP20020131A2 (en)
HU (1) HUP0202517A2 (en)
IL (1) IL147562A0 (en)
IS (1) IS6249A (en)
MA (1) MA26811A1 (en)
MX (1) MXPA02001514A (en)
NO (1) NO20020665L (en)
OA (1) OA11997A (en)
PA (1) PA8499201A1 (en)
PE (1) PE20010697A1 (en)
PL (1) PL353770A1 (en)
PT (1) PT1200605E (en)
SK (1) SK1382002A3 (en)
TN (1) TNSN00170A1 (en)
UY (1) UY26287A1 (en)
WO (1) WO2001012822A1 (en)
YU (1) YU8402A (en)
ZA (1) ZA200201071B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA200200056A1 (en) * 1999-08-12 2002-06-27 Пфайзер Продактс Инк. STREPTOMYCES AVERMITILIS GENE, GUIDES TO B2: B1 RELATIONSHIP
US6825204B2 (en) 2002-02-05 2004-11-30 Bristol-Myers Squibb Company N-substituted 3-hydroxy-4-pyridinones and pharmaceuticals containing thereof
CN1630712B (en) * 2002-02-12 2011-09-28 辉瑞产品公司 Streptomyces avermitilis genes directing the B2:B1 avermectin ratio
US7943160B2 (en) * 2002-05-09 2011-05-17 Scimetrics Limited Corp. Pest control methods
US8440609B2 (en) * 2003-01-31 2013-05-14 Gerd Wallukat Peptides against autoantibodies causing intolerance to cold and use thereof
KR100759130B1 (en) 2005-02-12 2007-09-19 휴메드 주식회사 Anti-integrin antibody coated stent and preparation method thereof
CN106148216B (en) 2015-03-27 2019-06-04 浙江海正药业股份有限公司 A kind of streptomycete and its method for producing mibemycin A3

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5238848A (en) 1987-01-23 1993-08-24 Pfizer Inc Cultures for production of avermectins
US5525506A (en) 1987-01-23 1996-06-11 Pfizer Inc. Process for production of avermectins and cultures therefor
US5234831A (en) 1987-01-23 1993-08-10 Pfizer Inc Cultures for production of B avermectins
US5240850A (en) 1987-10-23 1993-08-31 Pfizer Inc. Cultures for production of avermectin aglycones
DE3881147T2 (en) 1987-10-23 1993-09-02 Pfizer METHOD FOR PRODUCING AGLYCONES OF AVERMECTIN AND CULTURES CONTAINING THEM.
US5252474A (en) 1989-03-31 1993-10-12 Merck & Co., Inc. Cloning genes from Streptomyces avermitilis for avermectin biosynthesis and the methods for their use
DE69023036T2 (en) 1989-03-31 1996-06-13 Merck & Co Inc Cloning of Streptomyces avermitilis genes for the biosynthesis of avermectin and method of using them.
DK0711349T3 (en) 1993-07-30 2003-11-24 Pfizer Genes encoding branched alpha-ketoacid dehydrogenase complex from Streptomyces avermitilis
WO1995009863A1 (en) * 1993-10-05 1995-04-13 Pfizer Inc. Process and antiparasitic intermediates for doramectin
FI942725L (en) 1993-12-16 1995-06-17 Pfizer Genes encoding the branched-chain alpha-keto acid dehydrogenase complex from Streptomyces avermitilis
JP2002503473A (en) * 1998-02-13 2002-02-05 ファイザー・プロダクツ・インク Streptomyces avermitilis gene for B2: B1 avermectin ratio

Also Published As

Publication number Publication date
BR0013093A (en) 2002-08-13
HRP20020131A2 (en) 2003-12-31
CN1370239A (en) 2002-09-18
US20030134313A1 (en) 2003-07-17
US6248579B1 (en) 2001-06-19
US7259241B2 (en) 2007-08-21
ZA200201071B (en) 2003-06-25
UY26287A1 (en) 2001-03-16
AU5702100A (en) 2001-03-13
US20030129635A1 (en) 2003-07-10
YU8402A (en) 2006-03-03
PA8499201A1 (en) 2001-12-14
SK1382002A3 (en) 2002-11-06
HK1046536A1 (en) 2003-01-17
JP2005198658A (en) 2005-07-28
US20010016350A1 (en) 2001-08-23
US20050196777A1 (en) 2005-09-08
CO5290296A1 (en) 2003-06-27
US6509159B2 (en) 2003-01-21
OA11997A (en) 2006-04-18
HUP0202517A2 (en) 2002-11-28
AP2002002417A0 (en) 2002-03-31
BG106478A (en) 2004-02-27
US20010024818A1 (en) 2001-09-27
CZ2002297A3 (en) 2002-08-14
MXPA02001514A (en) 2002-07-02
EP1200605B1 (en) 2004-11-24
US6833263B2 (en) 2004-12-21
HK1046536B (en) 2005-05-13
CA2381427A1 (en) 2001-02-22
AU779756B2 (en) 2005-02-10
US7029887B2 (en) 2006-04-18
PT1200605E (en) 2005-04-29
WO2001012822A1 (en) 2001-02-22
KR20020022809A (en) 2002-03-27
NO20020665D0 (en) 2002-02-11
MA26811A1 (en) 2004-12-20
ES2231214T3 (en) 2005-05-16
IS6249A (en) 2002-01-25
GT200000138A (en) 2002-02-02
AR021450A1 (en) 2002-07-17
DE60016231D1 (en) 2004-12-30
AP2002002419A0 (en) 2002-03-31
US20030124607A1 (en) 2003-07-03
TNSN00170A1 (en) 2005-11-10
JP3688640B2 (en) 2005-08-31
US6511841B2 (en) 2003-01-28
US20030129636A1 (en) 2003-07-10
EA200200057A1 (en) 2002-06-27
JP2003507018A (en) 2003-02-25
IL147562A0 (en) 2002-08-14
KR100486006B1 (en) 2005-05-03
PE20010697A1 (en) 2001-07-05
EP1200605A1 (en) 2002-05-02
PL353770A1 (en) 2003-12-01
NO20020665L (en) 2002-02-11
CN1186447C (en) 2005-01-26
EA004569B1 (en) 2004-06-24
DE60016231T2 (en) 2005-12-08
ATE283363T1 (en) 2004-12-15

Similar Documents

Publication Publication Date Title
HUP0202639A2 (en) Immunostimulatory nucleic acids
BR9712878A (en) Subtilase enzyme variant, processes for the identification of a protease variant showing autoproteolytic stability and for the production of a mutant subtilase enzyme and a subtilase variant, DNA sequence, vector, microbial host cell, composition and use of a variant of subtilase.
DK1337648T3 (en) New cyclodextrin glucanotransferase (CGTase) from Bacillus agaradherens (DSM 9948) and detergents with this new cyclodextrin glucanotransferase
AU3246300A (en) Polypeptides having galactose oxidase activity and nucleic acids encoding same
EP1700915A3 (en) Enzymatic DNA molecules
CA2079454A1 (en) Steroid 5.alpha.-reductases
BR0003943A (en) Nucleotide sequences encoding the thre gene and process for the enzymatic production of l-threonine using corineforma bacteria
Colby et al. Insertional inactivation of the Streptococcus mutans dexA (dextranase) gene results in altered adherence and dextran catabolism
WO2003089606A3 (en) Thermostable dna polymerases and methods of making same
GT200000138CA (en) GENE OF STEPTOMYCES AVERMITILIS THAT DIRECTS THE RELATIONSHIP OF AVERMECTINES B1: B2 (FRACTIONARY APPLICATION NO.3, DERIVED FROM LAPATENT PI-2000-0138)
AP9901463A0 (en) Streptomyces avermitilis gene directing the ratio of B2:B1 avermectins.
AP2002002418A0 (en) Streptomyces avermitilis gene directing the ratio of B2:B1 avermectins.
CY1112491T1 (en) STREPTOMYCES AVERMITILIS GENE TESTING THE B2: B1 AVERAGE ANALYSIS
FR2792651B1 (en) GENOMIC SEQUENCE AND POLYPEPTIDES OF PYROCOCCUS ABYSSI, THEIR FRAGMENTS AND USES THEREOF
BR0110128A (en) Exopolysaccharide overproducing lactic acid bacteria mutant, use of it and nucleic acid encoding an alpha-phosphoglucomutase
HUP0400150A2 (en) Saponin-digesting enzymes, genes thereof and soyasapogenol b mass production system
ES2164545A1 (en) Enzymes with beta-(1,6)-endoglucanase activity
UA28735A (en) Defoaming agent for the process of bakers yeast cultivation